Correlation Between SAB Biotherapeutics and Evolus
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Evolus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Evolus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Evolus Inc, you can compare the effects of market volatilities on SAB Biotherapeutics and Evolus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Evolus. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Evolus.
Diversification Opportunities for SAB Biotherapeutics and Evolus
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between SAB and Evolus is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Evolus Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evolus Inc and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Evolus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evolus Inc has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Evolus go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Evolus
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 5.99 times more return on investment than Evolus. However, SAB Biotherapeutics is 5.99 times more volatile than Evolus Inc. It trades about 0.17 of its potential returns per unit of risk. Evolus Inc is currently generating about -0.26 per unit of risk. If you would invest 5.00 in SAB Biotherapeutics on August 27, 2024 and sell it today you would earn a total of 1.88 from holding SAB Biotherapeutics or generate 37.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 85.71% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Evolus Inc
Performance |
| Timeline |
| SAB Biotherapeutics |
| Evolus Inc |
SAB Biotherapeutics and Evolus Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Evolus
The main advantage of trading using opposite SAB Biotherapeutics and Evolus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Evolus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evolus will offset losses from the drop in Evolus' long position.| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals |
| Evolus vs. Collegium Pharmaceutical | Evolus vs. Phibro Animal Health | Evolus vs. ANI Pharmaceuticals | Evolus vs. Procaps Group SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |